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ABSTRACT Using a methodological perspective grounded in science and technology 
studies, this article analyzes two sociotechnical devices used in Argentine reproductive 
medicine (biostatistical measures and donation registries) with the aim of controlling 
both the so-called “genetic risk” arising from the use of donated ova as well as the health 
risks to female donors. By examining how the deployment of monitoring criteria dis-
regards the specificity of ova donation, the article suggests that it is not the absence of 
control measures and clinical criteria that produces an inadequate monitoring of such 
risks, but rather the concrete ways in which such measures are implemented that results 
in potential harms to the health of female donors.
KEY WORDS Fertilization In Vitro; Oocyte Donation; Women’s Health; Argentina.
RESUMEN Desde una perspectiva metodológica inspirada por los estudios en ciencia 
y tecnología, este trabajo analiza dos dispositivos clínicos (estándares bioestadísticos 
y registros de donación) que se utilizan en la medicina reproductiva argentina con el 
objetivo de controlar el denominado “riesgo genético” que se originan en el uso de 
óvulos donados, así como los riesgos para la salud de las mujeres donantes. Al examinar 
cómo la implementación de criterios de control desatiende la especificidad de la 
donación de óvulos, el artículo propone que no es la ausencia de criterios y controles 
clínicos en fertilidad lo que produce el inadecuado control de esos riesgos, sino que es la 
forma concreta en la cual se implementan tales controles lo que resulta en un potencial 
perjuicio para la salud de las mujeres donantes.
PALABRAS CLAVES Fertilización In Vitro; Donación de Óvulo; Salud de la Mujer; 
Argentina.
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INTRODUCTION
As part of a larger project that examined 
ova exchange in Argentina,[a] this article re-
flects on the care of women’s health, par-
ticularly of those women who “donate”[b] 
eggs to others for use in reproductive treat-
ments. The article aims to analyze the use 
of sociotechnical devices – the so-called 
“biostatistical measures” and “ova donation 
records” – through which reproductive med-
icine seeks to control the number of times a 
woman donates eggs. These devices aim to 
prevent two different risks: an increase in the 
probability of consanguinity, and the harm to 
women’s health. The article states, however, 
that the use of these devices is more focused 
on preventing the risks of endogamy rather 
than on reducing the health risks posed to 
female donors, a situation that impacts upon 
the chances of adequately monitoring the 
potential harm to the latter. Paradoxically, 
the ways in which these devices are imple-
mented imply new risks for the health of 
women.
Although assisted reproduction has been 
provided in Argentina for over thirty years, 
the field was regulated nationwide only re-
cently in June 2013, under the Medically 
Assisted Reproduction Act 26862. This leg-
islation ensures “full access” to reproductive 
treatments through both the public and 
private health systems regardless of sexual 
orientation, age, or marital status. Despite 
its democratic spirit and the fact that it was 
supported by a large sector of society, led 
by patient organizations and lesbian, gay, 
transvestite, transsexual, transgender, bi-
sexual, intersex, and queer (LGTTTBIQ) ac-
tivist groups, the act defined only broadly, 
or avoided to define altogether, important 
aspects of the implementation of repro-
ductive technologies. Among these aspects, 
the most important were the creation of 
gamete banks and a central donor record, 
whose lack of treatment in the Act ultimately 
affects the authentic fulfillment of the dem-
ocratic momentum of this act, in fact, under-
mining the right to benefit from reproductive 
technologies guaranteed by the legislation. 
As of June 2016, the effective implementation 
of this Act is far from meeting the expecta-
tions, since people who do not have health 
insurance, that is to say obra social (em-
ployment-based health insurance), or those 
without a pre-paid medical plan, will not 
have free access to the treatments provided in 
several locations, such as in the Autonomous 
City of Buenos Aires. Additionally, there have 
been delays and refusals from some health 
care providers regarding full coverage of 
the treatment, specifically diagnostic tests, 
drug coverage, etc.(3) Furthermore, national 
agencies have not taken the responsibilities 
that were vested in them by the Act so that 
they can fulfill the legislation (for example, the 
previously mentioned central donor registry). 
It is also important to mention that although 
the Act stipulates that “donation shall not be 
lucrative or commercial in nature,” donation 
is almost exclusively carried out by means of 
monetary exchange in all the private centers, 
while there is no free of charge gamete do-
nation scheme in the public field, as indi-
cated by the law.
In the context of a strong institutional-
ization, specialization, and professionalization 
that is taking place in Argentina and other 
countries of the region, the development of 
the reproductive medicine field is closely re-
lated to a rhetoric of the care of female fertility 
and women’s health in general.(4) Thus, on one 
hand, several Argentine clinics are extending 
their fertility services towards a larger range 
of interventions that seek to look after both 
reproductive and women’s health in general, 
addressing climacteric, cervical and breast 
pathologies, pelvic floor dysfunction, repro-
duction immunology, and the preservation 
of fertility. Sometimes, the services provided 
include nutrition, yoga, psychology, derma-
tology, beauty, plastic surgery, etc. These 
contribute to presenting fertility treatment as 
a space where health is tackled as a whole, 
avoiding the fragmentation of the body which 
was a central concern of early feminist cri-
tiques of assisted reproduction.(5,6,7)
On the other hand, in the specific case 
of oocyte donation, fertility clinics often 
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emphasize that both the mental and physical 
health of women donating ova(8) are con-
tinuously checked. This persistent rhetoric 
regarding the medical screening of the 
donor aims however to ensure that those 
who will receive donated ova will receive 
it from a “checked” woman, that is to say, 
from a woman whose reproductive history 
is already known, where the potential for 
genetic disorders, infections, or other type 
of diseases that could be transmitted to the 
descendant has been discarded to a certain 
extent, and for whom, as per the follicle 
count, an ovarian “good response” is pre-
dicted. The frequent reference to “having 
the patient checked” cannot be separated 
from the commercial conditions in which as-
sisted reproduction is offered in Argentina. 
Most treatments are offered only in private 
clinics and patients must pay large amounts 
of money for them. Within this context, the 
medical examination of the donor, even 
when formulated through a rhetoric of care or 
of compensatory schemes – where the donor 
is partially compensated for donating her ova 
through the provision of medical services, 
such as checking her reproductive health(9) – 
is, inevitably, an aspect of the medical inter-
vention taken as a “service” and, therefore, a 
component of the treatment’s cost. Its market 
value cannot be understated. 
The fact that the health of both patients 
and donors is taken care of does not mean 
that the health of women, especially female 
donors, is not at risk. In fact, being a donor 
in a reproductive treatment implies being ex-
posed to several health (and not only repro-
ductive) risks. Such risks arise not only from 
having ova removed as an isolated event (a 
surgical procedure with risks specific to this 
form of medical intervention, such as infec-
tions, anesthesia complications, bleeding, 
etc.), but also from the extraction of ova as 
a repeated event. The latter include the risk 
of developing different types of cancer, of a 
lessening of fertility, and of ovarian hyper 
stimulation syndrome.[c] These risks originate 
when the donor is involved as a supplier of 
clinical labor,(11) a type of bodily work in 
which the patient’s biology is involved.[d]
In light of these considerations, this ar-
ticle is concerned not only with the medical 
provisions regarding the (reproductive or 
other) health of female ova donors before, 
during, and after their participation in any 
fertility treatment. What is also examined 
is the way in which these estimates, regu-
lations, protocols, biostatistical measures 
or corporate assertions concerning the rel-
evance of monitoring potential risks to 
women’s health related to their status as ova 
donors, are actually performed in the clinical 
treatment of infertility. This is to say, it aims 
to contribute an understanding of the prac-
tical functioning of medical devices in con-
crete everyday situations, in this case related 
to the monitoring of the health of ova donors. 
Thus, this article explores the medical mech-
anisms through which harmful effects on the 
health condition of women who not only 
participate, but actually make possible, the 
very existence of egg donation schemes, are 
prevented. 
Studies of reproductive medicine in 
Iberoamerican countries
Unlike what happened in the English-speaking 
context, reproductive medicine has not been 
the subject of academic interest for the social 
and human sciences in the Spanish-speaking 
world. This may be so because, at least in Latin 
America, certain issues (such as the persistent 
illegality of abortion, maternal mortality or 
teenage pregnancy) mark more urgently the 
agenda of the social studies of reproductive 
health in most of the countries of the region. 
Below are presented a series of studies that 
do not intend to enumerate exhaustively the 
production in this specific area, but rather to 
point out the main issues tackled in regard to 
reproductive medicine, as well as the likely 
vacant areas still available for research. 
Regarding Argentina, the country where 
this study was conducted, research on re-
productive technologies within the human 
and social sciences was significantly limited 
until the beginning of the 2000s. However, 
in the past few years, several studies have 
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contributed specific knowledge to the field. 
Sommer(12,13) and Luna’s(14) pioneering re-
search shed light on gender asymmetry, 
the invasive nature of treatment, the experi-
mental conditions of many of the techniques, 
and the bioethical dilemmas represented by 
said techniques. Luna’s(15,16) research has 
especially emphasized the particularities 
of Latin America with respect to the imple-
mentation of reproductive techniques and 
the vulnerability context involved. Garay(17) 
has contributed with a feminist reflection on 
the role of gender in assisted reproduction. 
Raspberry(18) developed an ethnographic 
analysis of the ethical issues surrounding 
reproductive technologies, and Kemelmajer 
de Carlucci et al.(19) have contributed to the 
legal debate with a discussion of filiation as 
a result of the use of human reproduction 
techniques. Other legal aspects were studied 
by Calise,(20) who addressed the condition 
of excess embryos, and by Lloveras and 
Sapena(21) who paid attention to the potential 
regulation of preimplantation genetic di-
agnosis. Cuberli et al.(22) examined the ten-
sions between reproductive technologies 
and other practices that involve reproductive 
decisions such as abortion and HIV testing; 
Straw and Petracci(23) carried out a compar-
ative analysis of the use of reproductive tech-
nologies among middle and working class 
people in the City of Buenos Aires; Gemetro 
and Bacin(24) and Ariza and Libson(25) con-
tributed to a comparison of the use of re-
productive medicine in heterosexual and 
lesbian women. Ariza(26) studied the reasons 
argued by women for undergoing repro-
ductive treatment or not, the medical prac-
tices and the construction of ideas of the 
natural during gamete donation,(27) and pro-
vided a discussion of the activism that led to 
the inclusion of assisted reproduction in the 
Obligatory Medical Plan.(28)
As for the rest of the countries, in Spain 
there is need to mention the contribution 
made to an understanding of the legal as-
pects of ARTs by Puerto(29); Bestard’s(30) re-
search on the co-production of the social 
and the biological in reproductive tech-
nologies and its consequences for kinship; 
Jarufe Contreras’(31) study of non-biological 
filiation; Farnós Amorós’(32) contribution on 
reproductive tourism; the work by Rosset 
et al.(33) on the psychology of reproduction; 
and the tensions between subversive re-ap-
propriation and the repetition of traditional 
gender patterns in the use of reproductive 
techniques in Spain analyzed by Fernández 
Jimeno.(34) Regarding Latin American coun-
tries, there is the need to mention the re-
search conducted by Herrera et al.(35) on 
assisted reproduction and public opinion in 
Chile; the study of the (bio)ethics of assisted 
reproduction and its legal aspects conducted 
by several authors(36,37,38,39,40,41,42); the bio-
ethical and legal contributions on the right to 
personal identity and filiation among people 
born through gamete donation in repro-
ductive technologies(43,44,45,46); the analysis 
of the meanings of consent in reproductive 
medicine carried out by Albertoni Vazzaco 
et al.(47); Roberts’(48) ethnography of the status 
of the embryo in Ecuador; and the contribu-
tions from within psychology to an under-
standing of reproductive search by Escalante 
Barboza(49) and Lanius and Souza.(50) There is 
also an empirical Venezuelan study carried 
out by Romero Márquez(51) on the social rep-
resentations of assisted reproduction within 
a group of people that would potentially 
have access to it. 
In sum, what has been previously men-
tioned reveals that studies of assisted repro-
duction in Iberoamerican countries have 
been, in general, of a theoretical and nor-
mative nature, with very few examples of 
empirical case studies and the formulation 
of local research agendas. In this field, the 
production has tended to focus on bioethical 
and legal problems, leaving aside, generally, 
the analysis of the experiences of those who 
use the techniques, as well as of the medical 
practices. Sociology, the Anthropology of 
Medicine and Health, and Social Studies 
of Science and Technology have in general 
not gone into a detailed analysis of medical 
work, nor have they paid attention to the in-
teraction between human and non-human 
agents. Additionally, there is a considerable 
lack of research focused on gamete donation, 
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which includes the lack of studies on the po-
tential health risks to those women entailed 
in oocyte donation through reproductive 
technologies, like the ones that are being 
dealt with in this article. Lastly, it is worth 
noting that when non-biological filiation 
has been addressed in studies of assisted 
reproduction, the perspective has been ex-
clusively centered on the legal aspects and 
ethical principles involved rather than on the 
use of sociotechnical devices for managing 
risks. 
METHODOLOGY
The research study from which this paper 
derives adopted a methodological per-
spective based on Science and Technology 
Studies. To put it simply, these studies seek 
to explore the contemporary ways of doing 
science and technology(52) and of providing 
“inclusive knowledge of the origins, dy-
namics, and consequences” of them.(53 p.1) 
Even though at present it consists of a vast 
and multifaceted approach, the interest of 
Science and Technology Studies can be 
synthetized as getting to know the prac-
tices that generate scientific knowledge, 
the connections produced among science, 
technology, the State, economy, industry or 
laws, as well as the different ways in which 
different people participate in the formation 
of scientific goals and evaluate their re-
sults.(53) Science and technology studies are 
known for a certain aversion to generaliza-
tions regarding how knowledge or science 
behave and operate, mainly because they 
seek to study the concrete, specific, and 
local ways in which science is produced and 
knowledge is created. 
Regarding the historical background of 
the studies on science and technology, their 
origins can be located in the philosophy and 
sociology of scientific knowledge. In this 
regard, the work carried out by Karl Popper, 
Robert Merton, Ludwik Fleck, Thomas Kuhn 
and others has been key. In general terms, 
on the one hand these authors were seeking 
to explore the viability and operations of 
scientific knowledge (Popper, Fleck, and 
Kuhn). On the other hand, they sought to 
become familiar with the social conditions 
of knowledge, for example, the political 
determinations of scientific research pro-
grams or the norms and ferocious com-
petitions internal to the scientific field 
(Merton). Merton’s agenda would largely 
deal with the search for “external” expla-
nations for the progress of science, while 
Popper, Fleck, and Kuhn’s research would 
anticipate the involvement of philosophy 
and sociology in science itself. With these 
influences, back in the 1970s, a new field 
of study started to develop: the “Sociology 
of Scientific Knowledge.” This kind of so-
ciology did not seek to understand the social 
conditions of the production of scientific 
knowledge, but to analyze the content of 
science properly: how a set of theories that 
explain the phenomena are progressively 
creating knowledge about them through the 
construction of scientific facts in a non-te-
leological way. A new field thus began to 
open in the human and social sciences inter-
ested in studying science from an “internist” 
perspective, that is, interested in the study of 
the production of scientific facts.
Bruno Latour’s(55) “Laboratory Life: The 
Construction of scientific facts” stands as a 
landmark in this new perspective. This book 
inaugurated one of the most important tradi-
tions in the field of Science and Technology 
Studies, that of laboratory studies. The 
book is also one of the founding works of 
Actor-Network theory. Both Science and 
Technology Studies and Actor-Network 
Theory share essential aspects that differ-
entiate them from other branches of work 
in the human and social sciences. Some of 
those aspects are: a) ideas regarding the rel-
ativity of scientific truths (insofar as every 
scientific advancement is the result of a 
complex system of specific interactions be-
tween elements contingently located within 
the same discipline, research problem or 
work place, any scientific fact can only be 
contextual and located but, as such, a true 
fact); b) the idea that scientific knowledge 
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is real; and c) that scientific knowledge is 
constructed. 
During the 1990s and as a result of a 
series of events among which the “Sokal af-
fair”[e] stands out, such conception regarding 
the relative, constructed, and real character 
of scientific knowledge (a touchstone of 
Science and Technology Studies and Actor-
Network Theory) was radicalized. Such 
radicalization came about through a strong 
contrast with postmodern visions regarding 
the lack of objectivity, reality, and materi-
ality of the world and the science project 
that aims to know it, as well as the latter’s 
irredeemable determination by the “social 
conditions” of its production. 
As already mentioned, Actor-Network 
Theory is one important school of thought 
in Science and Technology Studies, within 
which this article is inscribed. This school is 
originally identified with the work of three 
authors: Bruno Latour, Michel Callon, and 
John Law. The theory was developed through 
case studies, particularly those involving 
laboratory practice, or economic activities 
such as Callon’s research in the French city 
of St. Brieuc Bay, among others.(56) Although 
the difficulty of describing in a general way 
the main aspects of the theory is often con-
ceded, a key element is its approach to the 
study of science and technology study “in 
the making,” that is, the study of the actors 
that make science and the place where it is 
made.(57) Other important elements are the 
Latourian imperative to “follow the actors” 
(that for Actor-Network Theory are not 
only human actors) who slowly build the 
“network” through which science and tech-
nology are made; and to “open the black 
box,” this is, to observe the micro-processes 
through which scientific and technologic 
facts are produced. In this exploration, 
Law(56) suggests that Actor-Network Theory 
must be understood as a “material-semi-
otics.” Taking the idea from semiotics that 
entities are defined only in relation with one 
another, he suggests applying this principle 
to all materials, not just those of a linguistic 
nature. Actor-Network Theory assumes that 
no entity (actor) stands for itself, but rather 
that it is performatized (acted, repeated, 
constructed) through a network, while any 
network is for sure the result of the agency 
of the actors involved. Law has summarized 
the actor-network theory as follows:
Actor-network theory is a disparate family 
of material-semiotic tools, sensibilities 
and methods of analysis that treats every-
thing in the social and natural worlds 
as a continuously generated effect of 
the webs of relations within which they 
are located. It assumes that nothing has 
reality or form outside the enactment of 
those relations. Its studies explore and 
characterize the webs and the practices 
that carry them. Like other material-se-
miotic approaches, the actor-network 
approach thus describes the enactment 
of materially and discursively heteroge-
neous relations that produce and reshuffle 
all kinds of actors including objects, sub-
jects, human beings, machines, animals, 
“nature,” ideas, organizations, inequal-
ities, scale and sizes, and geographical 
arrangements.(56 p.2)[f] 
Taking into account the contributions coming 
from Science and Technology Studies and 
from Actor-Network Theory, this study 
neither took for granted nor epistemologi-
cally privileged human action in the clinical 
ontologies that were studied. It focused on 
the fact that medical facilities are inhabited 
by human and non-human entities (medical 
apparatuses, administrative mechanisms, fa-
cilities, legal contracts, advertising material, 
medical statistics and protocols, oocyte and 
sperm, etc.), as well as entities whose human 
status is still under dispute or put on hold in 
Latin American societies, like embryos. Bruno 
Latour has stated that: 
No social science can be initiated unless 
who and what participates in the action 
is explored first, although this means 
allowing elements that are called, in 
other words, non-humans […] as soon 
as [objects] are released from the spell, 
they start to shake, stretch, murmur; they 
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start to wander everywhere, shaking the 
human actors and waking them from 
their dogmatic dream.(58 p.107-109)
In accordance with the above, Science and 
Technology Studies and Actor-Network 
Theory have been characterized for their 
emphasis on the analysis of the material and 
concrete aspects of the empirical realities 
studied, avoiding all-embracing syntheses 
regarding “the technique” or the expectation 
that a given technology would work the 
same way in the different places where it is 
implemented. As mentioned above, Science 
and Technology Studies and Actor-Network 
Theory have held a profound debate with 
post-structuralist streams that favor the idea 
that any object, entity, problem, identity, po-
litical project, scientific fact, etc., is the result 
of linguistic practices that construct meaning 
for human practices. Based on Foucault’s 
thought,(59) Science and Technology Studies 
and Actor-Network Theory believe that social 
construction can never be split from the 
physical devices through which it is enacted, 
and can never be reduced to written words. 
Therefore, before perpetuating the most lin-
guistic-oriented currents of social construc-
tivism and of the qualitative approach, which 
are often centered on the saying (rather than 
the doing) of the people examined, Science 
and Technology Studies have highlighted 
that an approach based only on ideas, cos-
movisions, or ideologies are at risk of leaving 
aside the central aspects of the problems ad-
dressed. Annemarie Mol has stated that: 
Instead of studying these topics by 
teasing out what doctors know or what 
happens to patient’s self-knowledge, I 
have analyzed the knowledge incorpo-
rated in practices [...] does not reside 
in subjects alone, but also in buildings, 
knives, dyes, desks [...] the material orga-
nization of medical practice shapes the 
reality of disease.(60 p.48) [g]
During 2008 and 2009, before the passing of 
the Medically Assisted Reproduction Act (Ley 
de Reproducción Médicamente Asistida), 
32 interviews were carried out with prac-
titioners of different medical specialties at 
fertility clinics. Because the field sites were 
restricted and, in some cases, difficult to 
access, most of the people involved were 
recruited through the sampling technique 
known as “snowball.” However, some of the 
respondents were contacted directly by the 
researcher through institutional or personal 
email or telephone. The interviews focused 
on practitioners’ daily work, usually through 
a series of general questions regarding how 
the fertility center works and other aspects 
on the medical specialty of the interviewee. 
Practitioners were from the following spe-
cialties: gynecology, biology, biochemistry, 
genetics, psychology and psychoanalysis, en-
doscopy, endocrinology, and clinical med-
icine. To select the different specialties, the 
extent of involvement of such specialties with 
the different medical areas of the clinic was 
evaluated. To select potential interviewees, 
it was made sure that they were working or 
had previously worked at a fertility center; 
therefore, self-employed practitioners were 
not considered. Given the difficulties in ac-
cessing this field, the only inclusion criteria 
for the selection of fertility clinics was that 
they had been established for over a year 
and that they had made successful treatments 
during the same period of time. 
During this research, scientists working 
on basic research in the area of fertility were 
also consulted. All interviewees signed an in-
formed consent form where they accepted to 
participate after having received information 
about the use and purpose of the information 
gathered. The data gathered and the identity 
of the people involved were kept confi-
dential. People working at seven different 
fertility clinics in the Autonomous City of 
Buenos Aires were interviewed. This research 
was approved by the Ethics Committee of 
Goldsmith’s Department of Sociology in the 
University of London. 
Throughout this research, different mate-
rials were gathered (informed consent forms, 
informative sheets, flyers, legislation pro-
posals, diagrams, evaluation forms, etc.), and 
their circulation and agency was analyzed 
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along that of human beings as part of the for-
mation of networks and of the material per-
formatization of ideas related to nature and 
procreation.(2,27,61,62)
Regarding the purpose of the interview, 
which is mainly a linguistic device, as a 
method to access the clinical ontologies 
studied, Mol’s(60) experience in applying 
this data collection instrument was taken 
into account. Mol suggests that only from 
a perspective that reifies the difference be-
tween body and mind, disease and feelings 
over disease, can the interview be conceived 
as a device that allows the access only to 
the meanings of what happens to the body 
(leaving aside the understanding of the body 
per se). On the contrary, Mol proposes that 
the interview must be applied to ask physi-
cians and patients “about what they do and 
the events that happen to them, rather than 
about their thinking,”(60 p.16) [h] getting away 
from the frequent reluctance of the social 
scientists to study the body, focusing only on 
studying the meanings and interpretations 
that people give to the body. This approach 
to the interview allows instead to unravel 
medical knowledge in a better way, some-
thing which “requires an investigation into 
clinical procedures and apparatuses rather 
than into the minds and cognitive opera-
tions of physicians.”(60 p.16)[i] The purpose of 
these interviews was, therefore, to establish 
the activities carried out by the practitioners 
interviewed. The interviews sought also to 
understand the ways in which these profes-
sionals interacted with the medical appara-
tuses and other daily life “practicalities”(60) of 
reproductive medicine, rather than looking 
only into the “deep meanings,” the “thinking 
systems,” and the “interpretations” and 
“meanings” that the people interviewed 
would assign to their daily work.
Once the interviews were finished, an 
analysis was carried out in order to answer 
the research question regarding the presence 
of ideas and practices about nature during 
gamete exchange in Argentina. Special atten-
tion was given to find, analyze, and under-
stand the ways in which the humans involved 
entwine their actions with medical appara-
tuses, seeking to know how the medical re-
alities studied are necessarily composed of 
semiotic and material elements, human and 
non-human nature. Partial results of these 
analyses(2,27,62) discuss the production of racial 
coherence and biological diversity as part of 
the instantiation of ideas and practices regard-
ing what is nature in assisted reproduction. 
As a correlate of this research, a number 
of articles have presented analyses of themes 
emerging from the data collection, such as 
the one discussed in this article. In this regard, 
although the main purpose of this research 
was not to understand how women’s health 
was addressed in medical fertility practices, 
the information collected allowed to es-
tablish an area of problematization regarding 
women’s health care, particularly donors. 
To analyze this dimension, the analysis pro-
ceeded in a way similar to the previous cases 
that is, paying special attention to how it can 
be considered that taking care (or not) of 
women’s health is, at least partly, the result 
of the interaction between human agents 
and biomedical apparatuses, insofar as such 
result cannot be attributed only to ideas, ide-
ologies, or forms of thought on the matter. 
Indeed, the research below shows that al-
though there is discursive support for the 
importance of preserving women’s health 
through reproductive medical practices, 
the consideration of the concrete practices 
through which such support should be en-
acted, as well as of the interactions between 
subjects and objects of medical practices, 
shows a different panorama than what was 
expected, that is, a certain disregard for the 
health of female donors. 
Based on Science and Technology Stud-
ies, Actor-Network Theory, and the inter-
views performed, the following paragraphs 
analyze the role of two specific medical 
devices, biostatical measures and clinical 
donation records. These are examined as 
mechanisms that monitor female donors’ 
health during fertility treatment. Insofar as 
they presuppose human action without be-
ing irrevocably reduced to it, the monitor-
ing mechanisms analyzed are considered 
socio-technical (that is, they show a certain 
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autonomy in the way they operate, yet this 
does not mean that human agency does not 
intervene at all). These apparatuses materi-
ally contribute to the organization of the 
clinical-scientific reality that, consequently, 
must be understood as produced by mate-
rial, corporal, and socio-technical practices, 
among others. The purpose is to show the 
considerable margin of action that they ac-
quire, as non-human entities, during fertility 
treatment, and to exemplify a perspective at-
tentive to the materiality and the “practicali-
ties”(60) of medical procedures. 
BIOSTATISTICAL MEASURES
The “genetic risk”
Modern biology is based on a series of prin-
ciples, among which is the law of variability. 
The theory of “natural selection” formulated 
by Charles Darwin,(63) which explains the 
prevalence or relative absence of certain bi-
ological features in a population, has as one 
of its main prerequisites the differences in the 
genetic constitution between individuals of a 
given population. This variation enables “en-
vironmental adaptation,” insofar as acquiring 
new features (due to mutation or crossbreed 
with another influx population, among other 
mechanisms) ensures the genetic renovation 
that make organisms and populations able 
to face changes in life conditions and, thus, 
overcome the danger of extinction. Genetic 
diversity is thus an exalted principle in the 
great narrative of modern biology. According 
to this narrative, those organisms whose fea-
tures better predispose them to survive in 
certain historical environmental conditions 
will be able to reproduce more offspring, 
their genes being widespread in a given pop-
ulation. The evolution of a population is the 
result of the relation between features that 
enable more and that enable less the rela-
tionship with the environment, a relation that 
is in itself made possible by variability among 
individuals. 
Reproductive medicine is no stranger to 
these ideas; on the contrary, these are central 
to the organization of medical services pro-
vided to people who cannot conceive with 
their own gametes. Guided by the impo-
sition of not contradicting the intrinsic ways 
in which life works, medical fertility ser-
vices are not only not separated from this 
notion but they also explicitly propose to re-
produce what is taken as the natural norma-
tivity.(1) Thus, references made to the need 
of ensuring genetic variability when using 
donated gametes, and the concomitant re-
sistance to violate the ways in which natural 
selection is thought to work, are extremely 
frequent in the semiotic-material practices 
of fertility practice. 
But what are the grounds for such insis-
tence? They stem from the medical concern 
that using gametes coming from the same 
donors increases the probability that two 
people that share ancestors “get to know 
each other and get married” (Gynecologist 4), 
causing the genetic pool to decrease. That is 
to say, if in fertility treatments both ova and 
sperm donors come from a limited pool with 
a low replacement rate which makes it that “it 
is always the same donors who donate,” there 
exists the probability that people conceived 
through these gametes reproduce together in 
the future, reducing the diversity of the popu-
lation. If these risks are confirmed, they would 
weaken the institutional orientation of fertility 
medicine as a service that imitates, rather 
than contradicting, the natural norm of vari-
ability. These risks are managed by using two 
socio-technical devices (biostatistical mea-
sures and donation clinical records), oriented 
to reducing such risks. This section explores, 
firstly, how in fact the first of these mecha-
nisms (biostatistical measures) works and, 
secondly, the risks posed to women’s health. 
Many professionals frequently refer to 
the “consanguinity risk” or the “genetic risk” 
when explaining the rationale for using a 
limited number of times a donor can donate. 
These limits, that some professionals call 
“biostatical measures,” are used in order to 
reduce the probability of encounter between 
people with the same ancestors. The mea-
sures used are generally expressed in the 
form of ratios that estipulate a certain number 
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of donations (or pregnancies or, to a lesser 
extent, births) for a specific population. For 
example, “25 pregnancies every 700,000 
inhabitants,” “1 birth every one million in-
habitants,” etc. These ratios[j] are mathemat-
ically calculated. Their definition follows a 
calculation regarding the probability of “en-
counter” of two “half siblings,” as the quote 
below reflects: 
We calculate as follows, how was it? It 
was 20 every million, this was the agreed 
upon number, 20 every million is the 
same as 1 every 100,000, in other words 
1 every 50,000. What is it that matters? I 
mean, why can’t there be more births? If 
there are 20 births within a population of 
one million, this would mean […] [that] 
in the future the probability of encounter 
between 2 half siblings is 1 in 50,000 
by 1 in 50,000. That is to say, 5 by 5 
is 25 and 4 zeroes on each side. What 
is the result of this calculation? Look at 
that, 2,500,000,000. 1 in 2.5 billion. I 
mean if I consider this figure, the proba-
bility is very low. If I raise the number of 
pregnancies, this number will decrease, 
making the encounter between two half 
siblings more likely. (Geneticist 1)
As this quote shows, the calculation that 
serves to regulate the risk of encounter be-
tween people with the same ancestors has 
an abstract character. Its use is not derived 
from studies (geographical, demographic, 
historical or sanitary) that serve to establish 
an appropriate consanguinity risk taking 
into account the relevant facts of a given 
real population (i.e. population density or 
degrees of consanguinity within its inhab-
itants) However, as described below, this 
abstract measure is used to regulate the risks 
held by the concrete bodies of women in 
ways that raise a few questions regarding its 
effectiveness. 
The abstract nature of biostatistical mea-
sures can also be observed in the use of 
medical guidelines with recommendations 
for setting a limit to the number of donations 
that will be accepted from one donor. The 
most quoted guidelines are, in fact, the “2008 
Guidelines for gamete and embryo donation: 
A practice committee report,” published 
by the American Society for Reproductive 
Medicine (ASRM) and the Society for Assisted 
Reproductive Technology (SART), two US or-
ganizations that include professionals working 
in reproductive medicine. As said above, 
these guidelines, published in 2008, are con-
stantly taken as a model by the practitioners 
working in the field in Buenos Aires. These 
guidelines, which are only for the case of 
sperm donation, recommend what is thought 
to be an appropriate number of times that a 
donor can donate reproductive material: 
It is difficult to provide a precise number 
of times that a given donor can be used 
because one must take into consider-
ation the population base from which 
the donor is selected and the geographic 
area that may be served by a given donor. 
It has been suggested that in a population 
of 800,000, limiting a single donor to no 
more than 25 births would avoid any 
significant increased risk of inadvertent 
consanguineous conception. This sug-
gestion may require modification if the 
population using donor insemination 
represents an isolated subgroup or if the 
specimens are distributed over a wide 
geographic area. (64)[k]
This recommendation aims to regulate the 
number of times gamete donation is allowed 
within a given population, that is, the pop-
ulation of the country where these recom-
mendations were made (in this case, the US). 
However, and despite these precautions, 
given the fact that there is no measure that, 
considering aspects of the local context such 
as geographical distribution and density, 
demographic history, sanitary reality, or re-
lationship degree within the inhabitants, 
etc., works appropriately in this context, 
Argentine professionals make use, in a de-
contextualized way, of the measure sug-
gested by the northern country. The omission 
of the specific conditions that allow for the 
implementation of this measure in the USA 
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(for example, of the epidemiological studies 
that would prove that the given measure is 
appropriate to prevent the risk of endogamy) 
undermines the concrete nature in which this 
measure is used in the USA, that is to say, the 
fact that the recommendation considers local 
information. Thus, Argentine fertility clinics 
implement in an unspecific way the measure, 
based on specific population criteria applied 
in the northern country, insofar as its imple-
mentation does not follow from a calculation 
that takes into account the specific character-
istics of Argentina’s population. This not only 
indicates the less concrete or less specific 
character of the application of this measure 
in Argentina when taken to the local context 
without any mediation from its original for-
mulation in the USA. It also shows the extent 
of the irrelevance of the question regarding 
the significance of the context in the trans-
lation or clinical application of measures for-
mulated in other contexts. 
Apart from this process of abstraction or 
elimination of the empirical bases that support 
the use of a specific measure, it can also be 
added that the American recommendations 
here commented on apply only to sperm do-
nation. In this regard, using this measure for 
ova donation, as it is done in Argentina, en-
tails a new process of abstraction, that is, an 
abstraction of the sex for which they ought 
to work. This transforms it into a measure 
used with independence of sex, a generic 
measure (applicable in a way which disasso-
ciates it from its context) which is also de-sex-
ualized. In this way, the risks specific to ova 
donation (its surgical nature, its dependency 
on hormonal stimulation, among others) are 
equally separated from the body, eliminating 
the question regarding the effect of a given 
number of donations (for example, 25) in the 
bodies of women who donate. 
Risks to the female donor
When asking about the use of measures that 
limit the number of donations for the sake of 
genetic risk, a different set of explanations 
(to the one above) were brought up among 
some of the people interviewed.. In effect, 
especially the women interviewed argued 
that besides the possible consanguinity risk, 
the limitation to the number of donations was 
based on the need to preserve the health of 
those women who donate ova. One of the 
women who participated indicated that, for 
example, the number that limits the amount 
of times a donor can donate: 
is related to the risk of ovarian cancer 
and to the risk of a potential diminishing 
of the ovarian reserve for that patient 
that, in future, is young and wants to 
have more kids. Generally, it is said that 
there is no relation with the alteration 
of the fertility nor with cancer […] but 
six is like a maximum number because 
just imagine, this is a poliovulation that 
occurs every three months and for the 
ovaries and the body it is a lot to cope 
with. (Gynecologist 2)
This testimony, taken from a female profes-
sional, indicates some of the concerns held 
by the reproductive field, and which are 
presented by some of its practitioners as an 
argument to justify the ways in which the ser-
vices are organized. In this case, the female 
professional talks about the possibility that 
the hormonal ovarian stimulation performed 
in ova donors may affect their health, espe-
cially in relation to the risk of cancer or of 
a diminishing of fertility. The professional 
explains that even though there is no actual 
medical risk,[l] there is a suggestion to limit the 
donation number as a precautionary measure 
since undergoing “poliovulation” – obtaining 
more than one mature egg as a consequence 
of ovarian hormone administration – every 
three months (minimum time frame between 
one stimulation and the next one) “is a lot to 
cope with […] for the ovaries […] and for the 
body.”
A second professional made her com-
ments along the same lines, although she 
emphasized the lack of appropriate local 
studies that monitor the health of female 
donors. In Argentina, female donors tend to 
donate more times than the advised amount, 
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by attending several clinics to donate the 
maximum number of times in each of them: 
All of the studies made were conducted 
20, 10 years ago. Whatever happens to 
the females who are donating now we 
know nothing about. Nowadays, female 
donors do not donate as the females 
in the past used to. They donate more; 
everything is much more widespread. 
(Gynecologist 1) 
However, testimonies about the potential 
risk to the health of those women who 
donate ova through their “clinical labor”(11) 
are fewer if compared to those arguments 
that, as quoted before, discuss the need of 
limiting the number of donations of the same 
donor due to the probability of consanguinity 
or the “genetic risk.” When discussing the 
risks involved, the following dialogue gives 
examples of the endogamy risk that predom-
inates in the discourse of professionals (espe-
cially male professionals): 
The Argentine Society for Reproductive 
Medicine [SAMER - Sociedad Argentina 
de Medicina Reproductiva] made a few 
recommendations that consider the epi-
demiology and make it so that when in 
the same population nucleus, a woman 
has already given one pregnancy per 
million inhabitants she must be dis-
carded [sic] (the same thing happens 
with sperm donors) to avoid endogamy, 
because the chances of endogamy in-
crease […] [when the same donor goes 
to different clinics] endogamy starts to 
increase and endogamy is not good for 
the species. It is bad for the species. 
Endogamy perpetuates many of the 
features, including those which are not 
useful or good to perpetuate, am I clear? 
(Gynecologist 4)
Can a donor donate forever? No [empha-
tic], because according to the WHO 
[World Health Organization] in a given 
population, only an x number of chil-
dren can be produced through gamete 
donation. This formula, that I believe is 
in a book, I believe it is in the Manual of 
Semen of the WHO, a formula where a 
female or male gamete donor can have 
up to x number of pregnancies. Why? 
Because if you exceed this number of 
pregnancies, the risk of consanguinity 
may appear. (Gynecologist 3) 
In this regard, the wider clinical resonance 
of the “consanguinity risk” (as opposed to 
the risk for female donors) shows an ambiv-
alence regarding the potential risks for the 
health of women who donate ova in fertility 
clinics. While some (two in particular) female 
professionals manifest the potential risks that 
female donors may experience, especially if 
they donate frequently, the main issue here 
is to prevent endogamy risk. This type of risk 
does not take into account the specificity of 
ova donation, its surgical nature, or the po-
tential risk of suffering a type of cancer re-
lated to fertility, a diminishing of fertility, or 
ovarian hyper stimulation syndrome (OHSS). 
This issue is also observed in the fact that 
the “Manual of Semen” serves as the origin 
of this measure. In this regard, as suggested 
by Cooper and Waldby(11) clinical labor in 
ova donors in the clinical fertility treatment 
causes specific risks that are not properly 
monitored despite the measures provided to 
control them. 
“Whatever happens first:” a random 
risk control
According to the previous paragraphs, two 
different risks are being controlled during 
fertility treatments. On the one hand, the 
idea is to regulate the loss of biological vari-
ability while on the other hand, although 
to a lesser degree, the aim is to control the 
risks to the donor. Indeed, on the one hand 
there are measures that – expressed in terms 
of number of donations, pregnancies, or 
births per number of inhabitants – are used 
to control the consanguinity risk; and on the 
other hand there are measures – expressed 
in terms of donations, pregnancies or births 
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per donor (such as “8 donations per donor,” 
“8 pregnancies per donor,” etc.) – that aim to 
monitor women’s health risk. 
However, in practice it is difficult to 
monitor these two risks simultaneously. 
How are, therefore, the different measures 
actually applied? When and under which 
criteria is the decision taken to apply a given 
measure to regulate the number of times 
a donor donates in a fertility clinic? The 
testimonies of the interviewed professionals 
show that there is no single answer to these 
questions. In fact, rather than an objective, 
agreed and universally applied criterion that 
succeeds in harmonizing the monitoring of 
the two types of risks (the consanguinity risk 
at the population level and the individual 
risk of women’s health), the biostatistical 
measures that control both risks are used 
interchangeably in reproductive medical 
practice. Some professionals mention that 
they use the population measure while others 
mention they use the individual measure. It 
may also happen that the same person uses 
both measures depending on the case. Thus, 
as it will be shown later in this article, which 
control measure will be used is left to chance,. 
This implies that, despite the impartiality 
and the apparently irrefutable character that 
numbers have, and their capacity to control 
risks in both a rational and exhaustive way, 
their use in reproductive treatment tends to 
preclude, rather than to allow, the appropriate 
control of the risks that surface, for both the 
population and the people involved in these 
procedures, from the use of donated gametes. 
Thus, the control of the risks involved in 
the use of gamete donation is inappropriate 
since, in the absence of a single measure that 
can compress the simultaneous monitoring of 
both risks (at the population and individual 
level), two combined measures which serve 
two different purposes are used in practice. 
As one of the interviewees states: 
Globally, there is a pre-set limit, a limit 
per donation that is based, on the one 
hand, on the consanguinity risk and, 
on the other hand, on the potential 
risk to the donor. This limit has been 
set in six donations, six punctures […] 
Consanguinity is given by a formula, I 
don’t know how to calculate it, which is 
25 live births every 800,000 inhabitants 
of the same area […] Thus, whatever 
happens first, whether it is more than 
25 born alive every 800,000 inhabitants 
or that the donor donates more than six 
times, this would be our limit. Usually, it 
is when they donate more than six times 
(Gynecologist 1)
What the previous quote shows is that since 
it is very difficult to simultaneously apply two 
measures that aim to control different types of 
risks, in practice measures are selected based 
on “whatever happens first.” This method has 
the effect of producing the organizational per-
ception that “the risks” have been controlled, 
the established protocols have been fol-
lowed, and that there is compliance with the 
scheduled process; a perception that does not 
address satisfactorily, however, the question 
about the effectiveness of the controls applied.
Indeed, what do the more or less random 
use of the two measures that limit, for dif-
ferent reasons, the number of times a female 
donor can donate produce in terms of the 
protection given to the health of female 
donors? The risk to women’s health resulting 
from their role as donors is not properly 
controlled when the measure applied is the 
population criteria for a certain number of 
donations, pregnancies, or births for a given 
population. In this case, and since this biosta-
tistical measure was mathematically obtained 
considering the probability of encounter be-
tween two “half-siblings,” its application 
raises questions regarding the effectiveness 
with which it can control the risk to women’s 
health involved in this clinical labor. The few 
studies that took place (in other countries) 
show that up to six donations per donor (or 
a number similar to this) do not affect the 
health of women (but they do not show how 
the latter is affected when the measure that 
is used is that consisting of 25 pregnancies 
every 700,000 inhabitants).
The analysis below presents other argu-
ments showing how the actual way in which 
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measures to control risks are utilized do not 
only fail to prevent the occurrence of certain 
risks, but actually multiply the chances of 
them occurring.
CLINICAL DONATION REGISTRIES
This section discusses how clinical donation 
registries are used to monitor the number of 
times a donor donates her ova in a repro-
ductive treatment. Like biostatistical mea-
sures, these registries are used to regulate 
the amount of times a donor donates her 
ova; this aims to decrease the probability 
of both genetic risk and risks to women’s 
health. Unlike biostatistical measures, the 
way these registries work is by “memorizing” 
the clinical activities stating what has been 
done (the number of times a woman has do-
nated) to establish, in future cases, whether a 
woman can continue donating or not.
Generally, professionals have shown 
a strong interest in how these registries are 
created and used, praising their effectiveness 
regarding the control of risks. However, 
since to date it has not been possible to 
create a collective registry that can gather the 
information collected from all the clinics[m] 
in Argentina, only intra-clinical donation 
registries are used. This is important given 
the “circulation” of donors among different 
clinics, which allows the exceeding of the 
stipulated amount of donations suggested by 
the biostatistical measures. Even though, as 
previously shown, clinics tend to control the 
number of times a donor donates, clinics do 
not have a way to verify whether that same 
donor donated or will donate to other fer-
tility clinics. This situation shows the het-
erogeneous rationalities (mainly ethical and 
economic) that are involved in the organi-
zation of gamete donation services, insofar 
as it is precisely the economic factor and 
the clinical need to count on a semi-stable 
pool of donors which collisions with the 
“ethical” impetus to protect the health of 
female donors. For example, a professional 
expressed the following: 
Just imagine, I went to this meeting at 
the Association [Argentine Reproductive 
Association] with two friends. On the 
way to the meeting they told me, they 
are both part of SAMER, they told me 
that two or three centers gathered and 
said “let’s see, get me ten donors, the 
records of ten donors, let’s do it.” And at 
one of these clinics, there was a woman 
who had donated fifteen times, fifteen! 
Imagine the number of pregnancies she 
has given to this clinic plus those she 
has given to other clinics! And I cannot 
be calling “Hey [doctor’s name] do you 
have a donor [by the name of X]?” It 
would be a mess because I would have 
to call thirty clinics… (Gynecologist 3)
As shown in the quote above, even though 
creating a collective registry of clinics is 
considered to be very important, until this is 
achieved fertility clinics are unable to control 
the compliance of women with the number 
of times they donate beyond the controls that 
the clinics have established. In this way, even 
though there is a sociotechnical mechanism – 
a clinical registry – that serves to control (up 
to a certain extent, as indicated in the para-
graph below) the number of times a female 
donor donates in a clinic, the fact that there 
is no collective registry that centralizes infor-
mation from all the clinics working in a spe-
cific geographic area, renders these control 
procedures less efficient. For this reason, the 
absence of either a state or private initiative 
to effectively create a collective registry en-
tails a lack of mechanisms that appropriately 
regulate the potential risk to women’s health. 
Meanwhile, the limit to the number of times 
a woman can donate her ova established 
within each clinic does not imply that said 
woman will not donate her ova to another 
fertility clinic(s) an equal number of times. 
Thus, this situation increases her exposure to 
the risks of donation (maybe unknowingly, 
if she has not been provided with adequate 
information[n]):
A donor will donate here an “x” number 
of times and then she will go to another 
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fertility center […] We have exclusive 
donation, that is, all of the ova which 
are recovered from a donor are for the 
recipient, but I cannot make sure that 
the same donor will [not] go to another 
clinic and donate. We do not go chasing 
after donors. (Gynecologist 7)
We have established a limit of up to 
six times for a donor to donate, but the 
patient that donated six times in this 
clinic, also donated six times in [name 
of the fertility clinic], six times in [name 
of the fertility clinic]. (Gynecologist 2)
Furthermore, the concrete way in which re-
cords are used in the fertility clinic implies 
that the regulation they propose or exemplify 
is not always effective. That is, although the 
interviewed professionals working at fertility 
clinics stated that, in most cases, they had the 
appropriate record, some testimonies show 
that these records are not always used as 
planned. A professional stated the following: 
Interviewee: Anyway, a donor should 
not donate many times. 
Interviewer: But is that rule always 
followed?
Interviewee: [Silence] … I don’t know… 
we try to […]
Interviewer: Do fertility clinics have reg-
istries such as “this is the last time that 
this donor donates” for example?
Interviewee: Yes, we do. “This donor 
cannot donate anymore…” The truth is 
that there are donors who are preferred 
over other donors, “what’s-her-name is 
coming,” because you know she has 
good ova, with a good probability of 
pregnancy, ova donation has a very 
good success rate. (Embryologist 1)
This testimony indicates that even though 
there is a clinical registry that stipulates 
whether a donor can donate again or not, “the 
truth” about the fertility clinics is that “there 
are donors who are preferred over others,” 
specifically those whose ova are “good” and 
have a good pregnancy probability. This 
alternative rationality, according to which 
is sought the maximum productivity of ova 
over the prevention of the potential risks for 
the donor’s health, entails that those donors 
whose ova are “nice” are more likely to be 
exposed to an increase in the probability of 
risk, since their ova are in higher demand 
and, as an exception, they can donate more 
than usual. 
CONCLUSION 
This article discussed the use of two so-
cio-technical devices (biostatistical measures 
and donation records) employed to regulate 
two risks that, according to the medical view, 
emerge from the use of donated gametes 
(ova). These risks are the probability that 
two people procreated from the same donor 
“meet and marry” in the future; together 
with the probability that the health of those 
women who donate is affected by the mere 
act of donating. In relation to biostatistical 
measures, this article showed that despite 
the pervasiveness of a rhetoric regarding the 
importance of biological variation, that pro-
motes the general understanding that it is 
important to prevent the risk of encounter 
between two “half-siblings,” there are also 
other, less clear concerns, that also exist 
among professionals of the field. These con-
cerns are in effect the fact that the health of 
female donors can be harmed, especially in 
relation to the probability of having cancer 
and future fertility problems. The presence 
of these two risks encourages the use of two 
different types of control measures: a popu-
lation measure, mathematically calculated 
and abstract, that regulates the probability 
of encounter between people with the same 
ancestors; and an individual measure, empir-
ically derived from a few studies in specific 
women that indicates a donation limit which 
has been proven to reduce major risks to 
women. However, insofar as it is very difficult 
to use these measures together in the clinic, 
the measures are randomly used (“whatever 
happens first”). Since each measure seeks to 
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control only one type of risk, and since it is 
impossible to regulate two risks at the same 
time, the outcome is that on some occasions 
the population measure is used to control the 
risk to women’s health, and in other occasions 
the individual measure is used to regulate the 
genetic (population) risk. Thus, the biostatis-
tical and abstract population measures which 
are derived from a mathematical probability, 
split from the concrete local conditions that 
provide a context for their use (geographical 
spread, relationship degree among indi-
viduals of a population, population or sanitary 
history), together with their sexual specificity 
(insofar as they are used irrespectively for 
both sperm and ova donation), are utilized to 
prevent the risk to the health of those concrete 
women who donate via their clinical labor(11) 
to fertility clinics. Likewise, although empir-
ically derived, individual measures that reg-
ulate the risk to women’s health are turned 
into abstract and separate from the reality of 
the women who donate, since they are taken 
from studies that took place in other regional 
contexts different from Argentina. 
Regarding the use of clinical donation 
registries, this article has shown that even 
though the majority of the clinics implement 
them as a control measure, the absence of 
synergies that ensure the construction of an 
inter-clinical registry that can centralize the 
information from all of the clinics implies 
that the risks to female health is not being 
appropriately regulated. While there are indi-
vidual clinical registries that serve to establish 
whether a donor can donate again or not, the 
lack of a central registry encourages the circu-
lation of donors among the different clinics, 
where they comply with their individual do-
nation limits, as seen in the testimonies of the 
professionals interviewed. As it is evident, 
the failure to have a centralized coordination 
makes it difficult to appropriately control the 
risks for the health of women who donate; a 
risk that is increased by the particular way in 
which clinical registries are used, that is, by 
making exceptions that favor the donation by 
certain donors (with “good” ova), although 
this might exceed the number of times it is 
convenient to donate. Additionally, it is also 
important to take into consideration, the po-
tential lack of information with which donors 
decide to donate to different fertility clinics, 
insofar as the lack of medical evidence of an 
association between ova donation and cancer 
or reduced fertility could be affecting the 
quality and type of information provided to 
donors in regard to this matter. 
The discussions presented help to con-
sider to what extent it is not about the absence 
of monitoring and prevention mechanisms re-
garding the health of donors, but about the 
way in which the actual implementation of 
such mechanisms jeopardizes the possibilities 
that these mechanisms have of performing 
their control tasks. At the same time, the de-
ployment of control mechanisms creates the 
corporate fiction that, since those mechanisms 
have been implemented, the risks involved 
have been adequately monitored. These 
findings open broader ethical questions re-
garding the participation of persons in experi-
mentation and donation in the contemporary 
bioeconomy, pointing out the presence of the 
specific risks that emerge from clinical labor, 
as well as to the need of controlling them 
adequately. 
The results herein presented point in 
the same direction as the tendency signaled 
by analyses already offered in other regions 
regarding the importance of biological as-
pects for native ways of understanding 
kinship. Thus, as this article points out, it 
is the concern for the possible future union 
between “half-siblings,” understood as those 
who share a genetic ancestor, that constitutes 
the focus of the activities of control at fertility 
clinics. This understanding, that suggest that 
in Argentina kinship is understood as strongly 
determined by the genetic component, at 
least among the practitioners interviewed, 
appears to be coextensive to a moral aspect: 
those who share genes shall not unite again. 
This confirms that suggested by Bestard(30): in 
the fertility clinic, social and biological as-
pects are coproduced, insofar as controlling 
the genetic risk also implies establishing pre-
caution against moral risks. 
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ENDNOTES
[a] The final result of this project was reflected in the 
doctoral thesis named “The normativity of nature: 
Morality, variability and kinship in the gamete 
exchange” (Goldsmiths, University of London). 
A different analysis in the use of biostatistical 
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measures, such as those examined in this article, 
was published under the title “Population-level 
management of kinship and normativity: the pro-
duction of biological viability in assisted reproduc-
tion’s gamete exchange”(1) (“Gestión poblacional 
del parentesco y normatividad: la producción 
de variabilidad biológica en el intercambio de 
gametas de la reproducción asistida”).
[b] For practical purposes, this article talks about 
ova “donation.” However, the term must be crit-
ically denaturalized, since in Argentina, ova 
exchange is paid and compensated with large 
amounts of money. For an analysis of the socio-
technical devices that produce the donation as 
such, refer to Ariza.(2)
[c] According to the American Society for Repro-
ductive Medicine (ASRM) “ovarian hyper stimu-
lation syndrome (OHSS) is an excessive response 
to the drugs that are used to enlarge ova (specially 
to the injectable gonadotropins).” OHSS produces 
large amounts of growing follicles, which leads to a 
liquid filtration to the abdomen, causing bloating, 
nausea, and swelling. In severe cases blood clots, 
shortness of breath, abdominal pain, dehydration, 
and vomiting can be found. In rare occasions, this 
syndrome can lead to death.(10)
[d] Cooper and Waldby(11) define “clinical labor” 
as a specific type of embodied work made by 
certain people (pregnancy surrogates, tissue and 
body parts providers, clinical studies partici-
pants) for the post-Fordism biomedical industry. 
According to these authors, the in vivo biology 
of certain human subjects is inscribed in con-
temporary work processes through the transfer 
of tissue or the experimental production of data 
experimental. These types of embodied work are 
increasingly central for the creation of value in the 
post-Fordism economy. In particular, expansion of 
markets linked to assisted reproduction demands 
ever more outsourced providers (as gamete sellers 
and pregnant surrogate) to satisfy the growing 
demand of reproductive services. This article con-
siders that ova donors are included within the defi-
nition of “clinical labor.”
[e] Physician and mathematician Alan Sokal sub-
mitted an article to the Social Text journal that was 
intentionally fraudulent and made use of a series 
of theories generically related to postmodernism, 
trying to show their lack of reasonableness. The 
article was indeed published in the journal, which 
generated a debate about the argument proposed 
by Sokal. 
[f] Original in English.
[g] Original in English.
[h] Original in English.
[i] Original in English.
[j] In a previous text(1) I have analyzed the sig-
nificant variation in the way in which ratios are 
quoted and used in the fertility centers. 
[k] Original in English.
[l] Initially, the (limited) investigation carried out 
mostly in central countries allow us to conclude 
that there is no relation between the intake of 
sexual hormones and cancer. However, related 
studies are still ongoing and have given no con-
clusive results. Cancer Research UK quotes, for 
example, a series of Danish, Dutch, Australian, 
and British studies that have shown the lack of 
relation between ovarian and breasts cancer, and 
the intake of reproductive hormones.(65) A 2006-re-
vision of the donation guidelines of the ASRM sta-
blished that there is no relation between ovulation 
stimulus agents and ovarian cancer, although it is 
clarified that “a definite conclusion still requires 
more studies.(64 p.S216) A 2004-report of the National 
Institute for Clinical Excellence (National Health 
Service, UK) states, however, that “women that 
are offered ovulation induction must be informed 
that the probable association between ovulation 
induction therapies and ovarian cancer remains 
uncertain.”(66 p.34) The fertility reduction of donors 
is, however, a different subject. The 2006 ASRM 
guidelines establish, for example, that “it is not 
presently known whether repetitive follicular 
aspirations could affect the donor’s future fer-
tility.”(64 p.S216)
[m] It must be noted that, even though the creation 
of a central gamete and/or embryo bank has been 
considered a need of the reproductive field for 
many years, it is also indicated by the Medically 
Assisted Reproduction Act (Ley de Reproducción 
Médicamente Asistida) passed in June 2013. 
However, such record has not been created yet. 
[n] This point should be investigated more thor-
oughly in upcoming studies. In effect, since there 
is medical consensus – based on a small group 
of studies made several years ago – that donating 
up to six or eight times does not harm the health 
of women, the message that is being given to the 
potential donors in the meetings is that “donating 
does not harm health.” The way this information 
is received and reinterpreted, especially in the 
context of economic need that marks the decision 
of many women to donate, entails the possibility 
that the probable health risks are unknown or ig-
nored by those women who decide to donate. 
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